Posatex Otic Suspension

Posatex Otic Suspension
Small 7.5g - plastic bottle
Medium 15g - plastic bottle
Large 30g - plastic bottle
SKU : 610375_-RX
Price: $20.95

Veterinarian Prescription (Rx) Required
Free Shipping on orders over $75
Low Price Match Guarantee


RX required for this item.
Click here for our full Prescription Policy and Form

Description

Posatex Otic Suspension is an anti-bacterial, anti-inflammatory and anti-fungal medication for dogs that treats otitis externa associated with susceptible strains of yeast and bacteria. 

Benefits

    • Anti-bacterial, anti-inflammatory and anti-fungal medication 
    • Simple once-a-day dosing into the ear canal
For Otic Use in Dogs Only


Dosage and Administration

Shake well before use. For dogs weighing less than 30 lbs. instill 4 drops of Posatex Otic Suspension once daily into the ear canal. For dogs weighing 30 lbs. or more, instill 8 drops once daily into the ear canal. Therapy should continue for 7 consecutive days.

Ingredients

Active Ingredients

Amount

Orbifloxacin

10 mg

Mometasone furote monohydrate

Equivilent to 1 mg mometasone furote

Posaconazole

1 mg

 

Cautions

Not for use in humans. Keep out of reach in children. Discontinue use if hearing loss is observed. 

 


Posatex Otic Suspension is a registered trademark of Intervet Inc., d/b/a Merck Animal Health, a subsidiary of Merck & Co. Inc.
Customer Reviews
(0.00)
# of Ratings: 0

RX required for this item.
Click here for our full Prescription Policy and Form


by Merck

Posatex Otic Suspension is an anti-bacterial, anti-inflammatory and anti-fungal medication for dogs that treats otitis externa associated with susceptible strains of yeast and bacteria.

1.0% Orbifloxacin, 0.1% Mometasone Furoate Monohydrate and 0.1% Posaconazole, Otic Suspension

  • Antibacterial
  • Anti-inflammatory
  • Antifungal

For Otic Use in Dogs Only

INDICATIONS: POSATEX™ Otic Suspension is indicated for the treatment of otitis externa in dogs associated with susceptible strains of yeast (Malassezia pachydermatis) and bacteria (coagulase positive staphylococci, Pseudomonas aeruginosa, and Enterococcus faecalis).

DOSAGE AND ADMINISTRATION: Shake well before use. For dogs weighing less than 30 lbs. instill 4 drops of POSATEX™ Otic Suspension once daily into the ear canal. For dogs weighing 30 lbs. or more, instill 8 drops once daily into the ear canal. Therapy should continue for 7 consecutive days.

EFFECTIVENESS: The effectiveness of POSATEX™ Otic Suspension was evaluated in a placebo-controlled, double-blind, multi-site field study. One hundred and ninety one dogs with naturally occurring clinical otitis externa associated with both yeast and bacteria were randomly allocated to either POSATEX™ Otic Suspension or placebo ointment. Of the 160 dogs evaluated for effectiveness, 122 were treated with POSATEX™ Otic Suspension and 38 were treated with placebo ointment. Treatments were administered once daily for 7 consecutive days. Assessment of effectiveness was based on improvement in clinical signs at re-evaluation 2-7 days following administration of the last dose.

Compared to the placebo, a significant percent of dogs treated with POSATEX™ Otic Suspension showed improvement in clinical signs (discomfort, erythema, and swelling) caused by otitis externa associated with one or more of the following organisms: Malassezia pachydermatis , coagulase positive staphylococci, Pseudomonas aeruginosa , and Enterococcus faecalis .

Percent of Dogs Showing Improvement in Clinical Signs of Otitis Externa

Clinical Sign

POSATEX™ Otic Suspension Group

Placebo Group

Significance

Discomfort

88%

45%

p<0.0001

External Ear Canal Erythema

81%

39%

p<0.0001

External Ear Canal Swelling

83%

49%

p=0.0001

ANIMAL SAFETY: POSATEX™ Otic Suspension was administered at 1,3, and 5 times the recommended dosage for 21 consecutive days. The control group received the vehicle in both ears at the clinical dose given five times per day. There was a slight decrease in serum cortisol concentration a er ACTH stimulation on Day 21 in the 5X group. Erythema was noted in all groups. Aural pain, swelling, or heat were each noted in 3 separate dogs in the 5X group.

Loading...